Science, Technology, and Innovation Minister Khairy Jamaluddin speaking during a joint news conference with the Health Ministry in Putrajaya, May 31, 2021. — Bernama pic
Subscribe to our Telegram channel for the latest updates on news you need to know.
KUALA LUMPUR, May 31 — The National Pharmaceutical Regulation Agency (NPRA) is assessing the suitability of using the Johnson & Johnson Covid-19 vaccine in Malaysia.
Science, Technology, and Innovation Minister Khairy Jamaluddin was responding to a question in today’s joint news conference with the Health Ministry on whether the US-made vaccine will be approved to be used in helping inoculate undocumented migrants in Malaysia.
Khairy who is also the National Covid-19 Immunisation Programme coordinating minister, said in March that Malaysia was in talks to procure the Johnson & Johnson vaccine.
He had expressed concerns about the supply then, adding that Johnson & Johnson had only offered some two million doses to Malaysia, and would only be able to deliver them towards the end of the year.
He said at the time that discussions were ongoing to improve the terms of the proposal.
MORE TO COME